A detailed history of Trust CO Of Virginia transactions in Eli Lilly & CO stock. As of the latest transaction made, Trust CO Of Virginia holds 23,762 shares of LLY stock, worth $18.9 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares
23,762
Previous 24,521 3.1%
Holding current value
$18.9 Million
Previous $22.2 Million 5.18%
% of portfolio
1.9%
Previous 2.14%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $586,054 - $728,655
-759 Reduced 3.1%
23,762 $21.1 Million
Q2 2024

Jul 26, 2024

SELL
$724.87 - $909.04 $183,392 - $229,987
-253 Reduced 1.02%
24,521 $22.2 Million
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $280,702 - $375,540
-474 Reduced 1.88%
24,774 $19.3 Million
Q4 2023

Jan 25, 2024

SELL
$525.19 - $619.13 $93,483 - $110,205
-178 Reduced 0.7%
25,248 $14.7 Million
Q3 2023

Oct 19, 2023

BUY
$434.7 - $599.3 $338,196 - $466,255
778 Added 3.16%
25,426 $13.7 Million
Q2 2023

Jul 31, 2023

BUY
$350.74 - $468.98 $172,213 - $230,269
491 Added 2.03%
24,648 $11.6 Million
Q1 2023

Apr 21, 2023

BUY
$310.63 - $364.82 $7.06 Million - $8.29 Million
22,734 Added 1597.61%
24,157 $8.3 Million
Q4 2022

Feb 01, 2023

SELL
$321.55 - $374.67 $32,155 - $37,467
-100 Reduced 6.57%
1,423 $520,000
Q3 2022

Oct 31, 2022

SELL
$296.48 - $337.87 $27,276 - $31,084
-92 Reduced 5.7%
1,523 $492,000
Q2 2022

Jul 22, 2022

SELL
$278.73 - $327.27 $22,298 - $26,181
-80 Reduced 4.72%
1,615 $524,000
Q1 2022

Apr 21, 2022

SELL
$234.69 - $291.66 $563,256 - $699,984
-2,400 Reduced 58.61%
1,695 $485,000
Q3 2021

Oct 27, 2021

BUY
$221.6 - $272.71 $541,812 - $666,775
2,445 Added 148.18%
4,095 $946,000
Q1 2021

May 07, 2021

SELL
$164.32 - $212.72 $12,324 - $15,954
-75 Reduced 4.35%
1,650 $308,000
Q3 2020

Nov 02, 2020

SELL
$146.22 - $169.13 $2,193 - $2,536
-15 Reduced 0.86%
1,725 $256,000
Q2 2020

Jul 29, 2020

SELL
$136.42 - $164.18 $8,185 - $9,850
-60 Reduced 3.33%
1,740 $286,000
Q1 2020

May 08, 2020

SELL
$119.05 - $147.35 $104,168 - $128,931
-875 Reduced 32.71%
1,800 $250,000
Q4 2019

Feb 06, 2020

SELL
$106.92 - $132.43 $10,692 - $13,243
-100 Reduced 3.6%
2,675 $351,000
Q2 2019

Aug 05, 2019

SELL
$110.79 - $129.32 $5,539 - $6,466
-50 Reduced 1.77%
2,775 $307,000
Q1 2019

May 08, 2019

SELL
$111.31 - $131.02 $25,601 - $30,134
-230 Reduced 7.53%
2,825 $367,000
Q4 2018

Feb 06, 2019

SELL
$105.9 - $118.64 $4,765 - $5,338
-45 Reduced 1.45%
3,055 $354,000
Q2 2018

Aug 07, 2018

BUY
$75.7 - $86.88 $234,670 - $269,328
3,100 New
3,100 $265,000
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $193,688 - $228,635
-2,610 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $38,921 - $41,747
-475 Reduced 15.4%
2,610 $220,000
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $237,760 - $263,890
3,085
3,085 $264,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Trust CO Of Virginia Portfolio

Follow Trust CO Of Virginia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Virginia , based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Virginia with notifications on news.